George C.

“I joined the Revolution because I wanted to join a company that gives people not just the hope of some extra time, but that can give people back the rest…

Continue ReadingGeorge C.

Dan H.

“To leave a fingerprint, however faint, on the science, and maybe, one day, the immune system itself. To fight alongside those whose motives are true. For my loved ones who…

Continue ReadingDan H.

Chris C.

“Getting the opportunity to put my own stamp on shaping the future supply chain that will bring life saving medicine to patients.“ — Chris C.

Continue ReadingChris C.

Bob T.

“I was eager to join Allogene for the people and the science. I get to work with intelligent, driven colleagues while studying the “crazy” science of treating recipient patients with…

Continue ReadingBob T.

Alice C.

“To find satisfaction in striving towards a collective purpose, to face the challenges of scientific innovation for improving (and saving) lives of fellow human beings.“ — Alice C.

Continue ReadingAlice C.

@AllogeneTx: Today we are announcing results from the ALPHA and ALPHA2 studies of our anti-CD19 AlloCAR T therapies in r/r non-Hodgkin lymphoma. Join us at 2:30PM PT/5:30PM ET to learn about the potential benefits of allogeneic cell therapy at our virtual CD19 Forum. $ALLO

Today we are announcing results from the ALPHA and ALPHA2 studies of our anti-CD19 AlloCAR T™ therapies in r/r non-Hodgkin lymphoma. Join us at 2:30PM PT/5:30PM ET to learn about…

Continue Reading@AllogeneTx: Today we are announcing results from the ALPHA and ALPHA2 studies of our anti-CD19 AlloCAR T therapies in r/r non-Hodgkin lymphoma. Join us at 2:30PM PT/5:30PM ET to learn about the potential benefits of allogeneic cell therapy at our virtual CD19 Forum. $ALLO